FDA authorizes ‘modified risk’ marketing for IQOS system

By |2020-07-20T11:55:14-04:00July 20, 2020|Point of Sale|

With the FDA’s recent authorization, Philip Morris can now market the IQOS system as ‘modified risk tobacco products’. We need to closely monitor how these products are being marketed and [...]